Amicus Therapeutics (FOLD) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Speaker0 Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics first quarter twenty twenty five financial results conference call and webcast. At this time, participants are in a listen only mode. Later, we will conduct a question and answer session, and instructions will follow at that time. As a reminder, this conference call, it is being recorded. I would now like to turn the conference call over to your host, ...

Amicus Therapeutics (FOLD) Q1 2025 Earnings Call May 01, 2025 08:30 AM ET Company Participants Andrew Faughnan - Vice President, Investor RelationsBradley Campbell - CEO, President & DirectorSébastien Martel - Chief Business OfficerJeffrey Castelli - Chief Development OfficerSimon Harford - CFOJoshua Fleishman - Biotech Equity Research Associate Conference Call Participants Anupam Rama - AnalystNone - AnalystDennis Ding - Vice President - Equity Research AnalystRick Miller - AnalystGil Blum - Senior Analyst ...